BUD31 antibody (BUD31 Homolog (S. Cerevisiae)) (AA 21-50)

Details for Product anti-BUD31 Antibody No. ABIN390083
Antigen
  • Cwc14
  • EDG-2
  • EDG2
  • G10
  • YCR063W
  • fSAP17
  • g10l
  • zgc:110615
  • CWC14
  • DDBDRAFT_0190998
  • DDBDRAFT_0233523
  • DDB_0190998
  • DDB_0233523
  • bud31
  • Edg2
  • C77604
  • g10
  • c77604
  • BUD31 homolog
  • BUD31 homolog (S. cerevisiae)
  • protein BUD31 homolog
  • U2 snRNP complex subunit BUD31
  • U2 snRNP complex subunit
  • hypothetical protein
  • BUD31 homolog (yeast)
  • BUD31 homolog L homeolog
  • maternal g10 transcript
  • Protein BUD31 homolog
  • BUD31
  • bud31
  • Bud31
  • bud31.L
  • LOC5569643
  • CC1G_08861
  • bud-31
  • LOC109464260
  • LOC108703088
Epitope
AA 21-50, N-Term
25
7
7
4
3
3
2
1
1
1
1
1
1
1
1
1
Reactivity
Human
95
57
41
8
7
5
4
4
4
2
2
2
2
2
2
2
2
2
1
1
Host
Rabbit
85
11
Clonality (Clone)
Polyclonal ()
Conjugate
This BUD31 antibody is un-conjugated
4
2
2
2
2
2
2
2
2
1
1
1
Application
Western Blotting (WB)
74
45
23
15
7
4
3
2
2
2
Options
Immunogen This EDG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-50 AA from the N-terminal region of human EDG2.
Clone RB01825
Isotype Ig Fraction
Specificity This EDG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 28~58 amino acids from the N-terminal region of human EDG2.
Purification This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Plasmids, Primers & others Plasmids, Primers & others BUD31 products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name EDG2 (BUD31 Antibody Abstract)
Background The EDG2 integral membrane protein is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion.
Molecular Weight 41109 DA
Gene ID 1902
NCBI Accession NP_001392
Application Notes WB = 1:1000
Restrictions For Research Use only
Format Liquid
Concentration 2 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Western Blotting (WB) image for anti-BUD31 Homolog (S. Cerevisiae) (BUD31) (AA 21-50), (N-Term) antibody (ABIN390083) The anti-EDG2 N-term Antibody (ABIN390083) is used in Western blot to detect EDG2 in ...
Product cited in: Boucharaba, Serre, Guglielmi, Bordet, Clézardin, Peyruchaud: "The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 25, pp. 9643-8, 2006 (PubMed). Method employed by authors: Western Blotting (WB)

Background publications Matsuda, Suzuki, Honda, Muramatsu, Matsuzaki, Nagano, Doi, Shimotohno, Harada, Nishida, Hayashi, Sugano: "Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways." in: Oncogene, Vol. 22, Issue 21, pp. 3307-18, 2003 (PubMed).

Shida, Kitayama, Yamaguchi, Okaji, Tsuno, Watanabe, Takuwa, Nagawa: "Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1." in: Cancer research, Vol. 63, Issue 7, pp. 1706-11, 2003 (PubMed).

Van Leeuwen, Olivo, Grivell, Giepmans, Collard, Moolenaar: "Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1." in: The Journal of biological chemistry, Vol. 278, Issue 1, pp. 400-6, 2002 (PubMed).

Did you look for something else?